Australia #8118 (v.2)

Datos básicos

Notificada en
Validez de la versión
17/04/2022 - actual
Versión activa actual v.2
Miembro informante
Australia
En vigor desde
Fecha de supresión
Suprimida el
Descripción general
Restriction on exports of COVID 19 rapid antigen test kits
Fundamento jurídico nacional
Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) (COVID-19 Rapid Antigen Tests) Determination 2022.

The Determination is made under subsection 477(1) of the Biosecurity Act 2015 (Cth).

The measure was in place from 8 January 2022. The measure ceased on 17 April 2022.
Mecanismo administrativo
The Determination prohibits the exports of COVID-19 rapid antigen test kits unless an exception under section 9 of the Determination applies. Section 9 outlines exceptions for both non-commercial and commercial purposes.

This is a temporary measure to ensure that COVID-19 rapid antigen test kits are reasonably and appropriately available to individuals who require a test, as part of Australia’s public health response to controlling the spread of COVID-19.
Entidades responsables
Versión del SA
HS 2017
Signatura de la OMC a que se hace referencia

Metadatos

Justificaciones en el marco de la OMC

XI:2(a) - (a) Export prohibitions or restrictions temporarily applied to prevent or relieve critical shortages of foodstuffs or other products essential to the exporting contracting party;

GATT 1994 (GATT 1947 provisions)

Notificada como: GATT Art XI. 2(a)
Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
Interlocutores afectados
Interlocutores no afectados

Medidas

Restricciones notificadas
CP-X
Signatura
CP-X

Líneas arancelarias

3822
3822.19.09
COVID-19 rapid antigen test kit